LEP and type 2 diabetes mellitus: Serum levels of leptin and IL-1 β were found to be significantly increased, and adiponectin decreased, in T2DM patients with MCI, suggesting that higher levels of leptin and IL-1 β, as well as lower levels of adiponectin, could be diagnostic biomarkers of MCI risk in elderly diabetes patients [14].